Biomark Diagnostics Inc. (CSE:BUX)

Biomark Diagnostics Revenue

Biomark Diagnostics had revenue of 38.99K CAD in the quarter ending June 30, 2025, with 1.77% growth. This brings the company's revenue in the last twelve months to 154.90K, down -4.26% year-over-year. In the fiscal year ending March 31, 2025, Biomark Diagnostics had annual revenue of 154.22K, down -5.52%.

• Revenue (ttm): 154.90K
• Revenue Growth: -4.26%
• P/S Ratio: 216.65
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 33.56M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2025	154.22K	-9.00K	-5.52%
Mar 31, 2024	163.22K	9.73K	6.34%
Mar 31, 2023	153.49K	109.56K	249.38%
Mar 31, 2022	43.93K	-	-
Mar 31, 2021	-	-	-